Health care industry
3 takeaways from the Investing Club’s ‘Morning Meeting’ on Monday
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Nvidia’s warning is a reset The bad news didn’t tank the market The Inflation Reduction Act could be bad for the market 1. Nvidia’s warning is a reset Nvidia (NVDA) […]
Read More
Hong Kong cuts hotel quarantine for travelers to 3 days, plus 4 days of home medical surveillance
Hong Kong is reducing the amount of time travelers will need to serve hotel quarantine, from seven days down to three starting Friday. “The seven-day quarantine hotel arrangement will be changed to three days in a quarantine hotel, plus four days of home medical surveillance,” Chief Executive John Lee said at a press conference Monday. […]
Read More
Senate passes sweeping climate, health and tax package, putting Democrats on cusp of historic win
U.S. Senate Majority Leader Chuck Schumer (D-NY) holds a news conference to tout the $430 billion drug pricing, energy and tax bill championed by Democrats at the U.S. Capitol in Washington, U.S. August 5, 2022. Jonathan Ernst | Reuters WASHINGTON — Senate Democrats narrowly passed a sweeping climate and economic package on Sunday, putting President […]
Read More
Republicans block cap on insulin costs for many Americans from Democratic deal
U.S. Senate Minority Leader Mitch McConnell (R-KY) speaks to reporters following the Senate Republicans weekly policy lunch at the U.S. Capitol in Washington, July 19, 2022. Elizabeth Frantz | Reuters Republican senators on Sunday voted down a cap on the price of insulin in the private market, removing it from Democrats’ sweeping climate and economic […]
Read More
Democrats’ big climate, health care and tax package clears major Senate hurdle
WASHINGTON — The Senate voted Saturday to advance a sweeping climate and economic bill with the support of all 50 Democrats, bringing long-stalled elements of President Joe Biden’s agenda one step closer to reality. The procedural vote on the filibuster-proof package was 51-50, with all Republicans opposing the motion to begin debate and Vice President Kamala […]
Read More
U.S. Senate Democrats’ bill will make mark on climate, health-care costs
U.S. Senate Majority Leader Chuck Schumer (D-NY) holds his weekly news conference after the Democratic caucus party luncheon at the U.S. Capitol in Washington, August 2, 2022. Jonathan Ernst | Reuters The $430 billion climate change, health-care and tax bill passed by the U.S. Senate on Saturday delivers a major win for Democrats, and will […]
Read More
Eli Lilly says Indiana’s abortion law will lead the drugmaker to grow in other states
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Mike Segar | Reuters Drugmaker Eli Lilly, one of the biggest employers in Indiana, said that the state’s newly passed law restricting abortions will cause the company to grow away from its home turf. […]
Read More
President Joe Biden tests negative for Covid-19 after rebound case
Jim Watson | Afp | Getty Images President Joe Biden tested negative for Covid-19 but will continue to isolate, according to the White House. Biden “continues to feel very well,” White House physician Kevin O’Connor said in a memorandum on Saturday. Despite his negative antigen test, “in an abundance of caution, the president will continue his strict […]
Read More
‘Stressed out’ STD clinics struggle to handle surge in monkeypox patients as U.S. outbreak grows
Dr. Emily Drwiega from the University of Illinois Health and Maggie Butler, a registered nurse, prepare monkeypox vaccines at the Test Positive Aware Network nonprofit clinic in Chicago, Illinois, July 25, 2022. Eric Cox | Reuters Dr. Ward Carpenter, co-director of health services at the Los Angeles LGBT Center, said the monkeypox outbreak across the […]
Read More
Artificial intelligence drug hunters are nearing a pivotal stage in their development
Efforts to use artificial intelligence to discover drugs have been underway for about a decade but industry watchers are predicting an inflection point is nearing for investors, who have been looking for ways to determine how AI-first drug developers should be valued. AI and machine learning offer the potential to speed up the hunt for […]
Read More